BC
SNDX icon

BIT Capital’s Syndax Pharmaceuticals SNDX Stock Holding History

BIT Capital’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-87,997
Closed -$1.69M – 140
2024
Q3 		$1.69M Buy
87,997
+8,211
+10% +$170K 0.16% 51
2024
Q2 		$1.64M Buy
79,786
+12,822
+19% +$268K 0.13% 60
2024
Q1 		$1.59M Buy
66,964
+58,910
+731% +$1.31M 0.12% 73
2023
Q4 		$174K Sell
8,054
-29,246
-78% -$450K 0.02% 75
2023
Q3 		$542K Hold
37,300
– – 0.06% 69
2023
Q2 		$781K Buy
37,300
+11,882
+47% +$247K 0.07% 81
2023
Q1 		$537K Buy
25,418
+4,737
+23% +$118K 0.08% 88
2022
Q4 		$526K Sell
20,681
-80
-0.4% -$1.87K 0.11% 74
2022
Q3 		$499K Buy
+20,761
New +$466K 0.09% 68

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BIT Capital's SNDX Position: Q4 2024 in Review

BIT Capital sold out of Syndax Pharmaceuticals (SNDX) in Q4 2024, closing a stake of 87,997 shares — an estimated $1.69M sold.

BIT Capital first reported a position in SNDX in Q3 2022 and held it in 9 quarters. The position peaked at $1.69M in Q3 2024. 215 funds tracked by Wall St. Rank hold SNDX as of Q4 2024.

  • BIT Capital reported no remaining Syndax Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • BIT Capital sold 87,997 Syndax Pharmaceuticals shares in Q4 2024, an estimated $1.69M.
  • BIT Capital first reported a position in Syndax Pharmaceuticals in Q3 2022 and held it in 9 quarters.
  • BIT Capital's Syndax Pharmaceuticals position peaked at $1.69M in Q3 2024.
  • 215 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2024.

Based on BIT Capital's 13F filing for Q4 2024, filed 12 Feb 2025.